Our royalty from Edding on China revenue is about 15-18%. So whatever China is reimbursing, figure we take that percentage as royalty. So while China is nice, our revenue will be modest there.
On top of that, it’s probably 18-24 months before we see a dime of revenue from China.
Like most of EU, the market places little value on anything Amarin achieves until it results in actual revenue.
I don't get the "if" This IS the plan and he's done it before. The alternative is GIA and that is not his MO He WANTS to sell the company and he'll do it when the price is right.
cbb..."Once pricing was determined in the world outside of the US, then the BP launches a US branded generic"
Low prices for large volume purchases of EPA from wholesalers + low prices for large volume sales of a Vascepa authorized generic = significant profits for a BP and better health for patients....QED
News 
Market Data 
Discover 
